Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ARG1 | P05089 | 1/20 | 0.45 |
| ▸ | ARG2 | P78540 | 1/20 | 0.45 |
| ▸ | PARP1 | P09874 | 1/20 | 0.32 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.30 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.30 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.30 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.30 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1360119 | 0.95 | ARG1 (0.49) | ARG1ARG2PARP1CYP2D6SLC6A2 | |
| SCHEMBL1360118 | 0.95 | ARG1 (0.49) | ARG1ARG2PARP1CYP2D6SLC6A2 | |
| Hydrochloric Acid SCHEMBL30382824 | 0.93 | ARG1 (0.47) | ARG1ARG2PARP1CYP2D6SLC6A2 | |
| Hydrochloric Acid SCHEMBL4684924 | 0.93 | ARG1 (0.47) | ARG1ARG2PARP1CYP2D6SLC6A2 | |
| SCHEMBL21645480 | 0.88 | ARG1 (0.43) | ARG1ARG2PARP1 | |
| SCHEMBL28516379 | 0.79 | ARG1 (0.37) | ARG1ARG2 | |
| SCHEMBL14265250 | 0.78 | ARG1 (0.54) | ARG1ARG2CYP2D6SLC6A2SLC6A4 | |
| SCHEMBL12764363 | 0.77 | ARG1 (0.36) | ARG1ARG2PARP1CYP2D6SLC6A2 | |
| SCHEMBL8190743 | 0.77 | ARG1 (0.36) | ARG1ARG2PARP1CYP2D6SLC6A2 | |
| SCHEMBL3676543 | 0.76 | ARG1 (0.54) | ARG1ARG2CYP2D6SLC6A2SLC6A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112423774-A | Therapeutic compositions and methods of use for treating mild cognitive impairment, depression and psychological disorders | L·H·L·特兰 | 2021-02-26 | — | — | CN | claimed |
| CN-112423774-A | Therapeutic compositions and methods of use for treating mild cognitive impairment, depression and psychological disorders | L·H·L·特兰 | 2021-02-26 | — | — | CN | disclosed |